Mélanie Guyot - Concepedia

Author

Mélanie Guyot

Centre National de la Recherche Scientifique ORCID

Also Known As

Guyot, Mélanie, Melanie Guyot, Mélanie Guyot

Publications

587

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Université Côte d'Azur Inserm Scientific Centre of Monaco Institut de Pharmacologie Moléculaire et Cellulaire

About

Mélanie Guyot is an author at Centre National de la Recherche Scientifique specializing in medicine, tumor biology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	178
2	Health Sciences	1	1	39
3	Social Sciences	1	1	53
4	Cell Biology	1	1	53
5	Diabetes	1	1	53

Mélanie Guyot

Publications

542

Citations

H-Index

Page 1

	Year	Citations
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma Renaud Grépin, Mélanie Guyot, Sandy Giuliano, Cancer Research	2013	123
Apical splenic nerve electrical stimulation discloses an anti-inflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells Mélanie Guyot, Thomas Simon, Clara Panzolini, Brain Behavior and Immunity	2019	83
CD8+ T cells are essential for the effects of enriched environment on hippocampus-dependent behavior, hippocampal neurogenesis and synaptic plasticity Hadi Zarif, Sarah Nicolas, Mélanie Guyot, Brain Behavior and Immunity Synaptic PlasticityDevelopmental BiologyHippocampal NeurogenesisDevelopmental Cognitive NeuroscienceMedicine	2017	53
Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes Mélanie Guyot, Thomas Simon, Franck Ceppo, Nature Biotechnology Autoimmune DiseasePhysiologyImmunologyDiabetesAutoimmunity	2019	53
VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy Caroline Hilmi, Mélanie Guyot, Gilles Pagès Journal of Nucleic Acids UrologyAngiogenesisNovel Splice VariantsAnti-angiogenesis TreatmentVegf Splicing	2011	39
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor Renaud Grépin, Mélanie Guyot, Aurore Dumond, Theranostics	2019	35
The cholinergic anti-inflammatory pathway inhibits inflammation without lymphocyte relay Thomas Simon, Joseph Kirk, Nikola Doležalová, Frontiers in Neuroscience	2023	35
Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment Cécile Ortholan, Jérôme Durivault, Jean‐Michel Hannoun‐Lévi, European Journal of Cancer OncologyTherapeutic EffectBevacizumab/docetaxel AssociationMedicineImmune Checkpoint Inhibitor	2010	33
CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas Maeva Dufies, Sandy Giuliano, Julien Viotti, British Journal of Cancer	2017	30
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies Mélanie Guyot, Caroline Hilmi, Damien Ambrosetti, Oncotarget	2016	26

Page 1